Darkome

During the Decade of Plagues, pandemics brought civilization to a standstill. The only way out was the Aspis chip: a wearable mRNA vaccine factory, able to immunize you against new viruses on the fly. But not everyone wanted it. They created an open alternative: Darkome, an underground community of biohackers modifying their own genes and bodies.

Inara came of age in a Darkome village - but only an Aspis could keep her rare cancer in check, updating her immune system at a pace with her cancer's evolution. Accepting it went against everything Darkome stood for. She had to choose between her community and her life.

Now Inara's Aspis appears to have malfunctioned. She can edit her own DNA to be stronger, faster, smarter. It could be the genetic breakthrough of the millennium, but only if she can figure out how it works . . . and to stay ahead of those who will stop at nothing to possess her secret. Pursued by Aspis, Darkome radicals and the government, her new abilities may be the only way for Inara to survive. But they may cost her everything, including her humanity.

Hannu Rajaniemi was born in Finland. At the age of eight he approached the European Space Agency with a fusion-powered spaceship design, which was received with a polite "thank you" note. Hannu studied mathematics and theoretical physics at University of Oulu and Cambridge and holds a PhD in string theory from the University of Edinburgh. He co-founded a mathematics consultancy whose clients included UK Ministry of Defence and the European Space Agency.

Hannu is the author of four novels including The Quantum Thief (winner of 2012 Tahtivaeltaja Award for the best science fiction novel published in Finland and translated into more than 20 languages). His most recent book is Summerland (June 2018), an alternate history spy thriller in a world where the afterlife is real. His other works include Invisible Planets: Collected Fiction, a short story collection.

Hannu lives in the San Francisco Bay Area. He is a co-founder and CEO of HelixNano, a venture- and Y Combinator backed biotech startup.

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.